It’s estimated that 90% of retail investors lose money. We help you beat those odds with concise research, education, and more. Click here to see our offerings.
- Adial Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for addictions
- ADIL’s lead asset (AD04) is in Phase 3 of development as a therapy for Alcohol Use Disorder (AUD)
- The company is targeting individuals with AUD and a certain genetic makeup conducive for the treatment